Home Apyx Medical Corporation

Apyx Medical Corporation

Apyx Medical Corporation Initiates Enrollment in Study Evaluating the Use of Renuvion® Technology in Skin Laxity Procedures in the Neck and Submental Region

Apyx Medical Corporation October 14, 2019

The study is a prospective, multi-center, multi-phase, evaluator-blinded study designed to evaluate the safety and effectiveness of Renuvion technology when used to improve the appearance of lax tissue in the neck and submental region.

LEARN MORE

Launch of Renuvion™: A New Brand Dedicated to the Cosmetic Surgery Market Announced by Bovie Medical Corporation

Apyx Medical Corporation March 29, 2018

3/29/18: Bovie Medical’s J-Plasma technology will now be marketed and sold in the cosmetic surgery market under the brand name, Renuvion.

LEARN MORE

Bovie Medical Receives 510K Clearance for its J-Plasma® Precise Flex Handpiece

Apyx Medical Corporation May 8, 2017

The Addition of the J-Plasma® Precise Flex rounds out Bovie Medical’s J-Plasma® offering to include products designed for open and minimally invasive surgical procedures,...

LEARN MORE

Boston Scientific to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference

Apyx Medical Corporation May 1, 2017

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017 Healthcare Conference on Thursday, May 18, 2017...

LEARN MORE

Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece

Apyx Medical Corporation March 27, 2017

Bovie Medical (NYSE:BVX) announced today that it has received 510K clearance from the FDA for a new J-Plasma® generator and handpiece that incorporate Cool-Coag™...

LEARN MORE

RECENT COMMENTS

Prof Sherif Sultan on Perfect AAA EVAR Stent Has Not Been Designed or Produced: All Current AAA EVAR Devices are Obsolete

Khaled mohamed fekry saleh on Perfect AAA EVAR Stent Has Not Been Designed or Produced: All Current AAA EVAR Devices are Obsolete

Medical Device News Magazine on Neurolief’s Relivion™ Digital Therapeutics Brain Neuromodulation Technology Featured at Headache Symposium in Israel

Paula on Neurolief’s Relivion™ Digital Therapeutics Brain Neuromodulation Technology Featured at Headache Symposium in Israel

Helen on New Study Validates Rigorous Safety Measures Needed To Reduce Mercury Exposure During Dental Amalgam Filling Removal

JP on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Teresa Franklin on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Cynthia Easter on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Rob Abbot on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Teresa Franklin on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Eugenia McGrath on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Helen on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Molly Hauck on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Eric Uram on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Patrick on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

Michael Bender on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed

ganka on New Cochlear™ Nucleus Sound Processor® Profile™ Plus Series Cochlear Implant and Nucleus 7 Sound Processor Receive FDA Approval

Airtech Equipment Pte Ltd on Leaf Healthcare, Inc. Acquired by Smith & Nephew

Harry on Experts Discuss How They’ve Adopted TransCarotid Artery Revascularization (TCAR)

Juan C Parodi on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

Bergantini Hélio on First Patient Treated in First-in-Man Study of Deep Vein Thrombosis Treatment Designed to Remove Wall-Adherent Clot in Single Session, without Thrombolytic Drugs

Osama on First Patient Treated in First-in-Man Study of Deep Vein Thrombosis Treatment Designed to Remove Wall-Adherent Clot in Single Session, without Thrombolytic Drugs

dr.ashwin bhammar on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

Ilene on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

Amy Lewis on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke

M Subramaniam on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them

Harry on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them

Sherif on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them